We are live on ! Find out more
JF

Jump Financial Portfolio holdings

AUM $7.5B
1-Year Est. Return 33.9%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
AUM
$9.08B
AUM Growth
+$1.8B
Cap. Flow
+$662M
Cap. Flow %
7.3%
Top 10 Hldgs %
14.49%
Holding
2,261
New
727
Increased
579
Reduced
415
Closed
516

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$149M
2
AAPL icon
Apple
AAPL
+$78.6M
3
MSFT icon
Microsoft
MSFT
+$75.8M
4
COST icon
Costco
COST
+$55.6M
5
PLTR icon
Palantir
PLTR
+$47.8M

Sector Composition

Rank Sector Weight
1 Technology 19.71%
2 Healthcare 10.66%
3 Consumer Discretionary 9.74%
4 Industrials 9.64%
5 Financials 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPIC
1701
DELISTED
TPI Composites
TPIC
$17.1K ﹤0.01%
+19,926
New +$20.3K
DCGO icon
1702
DocGo
DCGO
$64M
$16.3K ﹤0.01%
+10,404
New +$19.4K
POWW icon
1703
Outdoor Holding Co
POWW
$253M
$16.2K ﹤0.01%
+12,687
New +$20.1K
GRWG icon
1704
GrowGeneration
GRWG
$88.3M
$15.5K ﹤0.01%
+16,568
New +$17.7K
LXRX icon
1705
Lexicon Pharmaceuticals
LXRX
$1.03B
$15.1K ﹤0.01%
+15,993
New +$10.4K
PACB icon
1706
Pacific Biosciences
PACB
$441M
$14.8K ﹤0.01%
11,900
-9,513
-44% -$11K
MGNX icon
1707
MacroGenics
MGNX
$243M
$14K ﹤0.01%
+11,534
New +$16.7K
ZNTL icon
1708
Zentalis Pharmaceuticals
ZNTL
$331M
$13.6K ﹤0.01%
+11,692
New +$15.4K
PROK icon
1709
ProKidney
PROK
$320M
$13K ﹤0.01%
+21,922
New +$17.1K
HOWL icon
1710
Werewolf Therapeutics
HOWL
$17.9M
$12.4K ﹤0.01%
+11,345
New +$11.7K
NMRA icon
1711
Neumora Therapeutics
NMRA
$304M
$11.5K ﹤0.01%
15,691
-9,256
-37% -$7.01K
UP icon
1712
Wheels Up
UP
$227M
$10.9K ﹤0.01%
+509
New +$12.5K
RDZN icon
1713
Roadzen
RDZN
$103M
$10.2K ﹤0.01%
+10,389
New +$10.4K
NOTE
1714
DELISTED
FiscalNote
NOTE
$9.7K ﹤0.01%
+1,507
New +$11.3K
NRGV icon
1715
Energy Vault
NRGV
$553M
$8.38K ﹤0.01%
+11,697
New +$9.45K
TNYA icon
1716
Tenaya Therapeutics
TNYA
$158M
$6.47K ﹤0.01%
+10,590
New +$5.39K
OVID icon
1717
Ovid Therapeutics
OVID
$435M
$4.53K ﹤0.01%
+13,718
New +$4.13K
LNAI
1718
Lunai Bioworks
LNAI
$10.8M
$3.97K ﹤0.01%
+172
New +$4.8K
MRSN
1719
DELISTED
Mersana Therapeutics
MRSN
$3.35K ﹤0.01%
+453
New +$3.98K
GBIO
1720
DELISTED
Generation Bio
GBIO
$3.29K ﹤0.01%
+1,028
New +$3.96K
APLT
1721
DELISTED
Applied Therapeutics
APLT
$3.15K ﹤0.01%
+10,122
New +$3.92K
NCNA
1722
NuCana
NCNA
$5.62M
$963 ﹤0.01%
+84
New +$5.77K
A icon
1723
Agilent Technologies
A
$39.5B
-192,325
Closed -$22.5M
AB icon
1724
AllianceBernstein
AB
$3.46B
-100,318
Closed -$3.84M
ACCO icon
1725
Acco Brands
ACCO
$399M
-37,607
Closed -$158K

Similar funds

Jump Financial's Q2 2025 Portfolio in Review

As of Q2 2025, Jump Financial held 2,261 positions worth $9.08B, up 25% from $7.27B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Jump Financial deployed $662M of net new capital in Q2 2025, opening 727 new positions and adding to 579 existing holdings. Its largest new stake was Apple: 389,136 shares worth $79.8M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Strategy Inc, an estimated $85.4M trimmed.

  • Jump Financial's largest Q2 2025 buy was Apple: 389,136 shares worth $79.8M.
  • Jump Financial added most to iShares Russell 2000 ETF in Q2 2025, an estimated $149M increase.
  • Jump Financial's biggest Q2 2025 reduction was Strategy Inc, cutting an estimated $85.4M.
  • Jump Financial fully exited State Street Technology Select Sector SPDR ETF in Q2 2025, selling an estimated $91.5M.
  • Jump Financial's ten largest holdings make up 14% of its $9.08B portfolio in Q2 2025.
  • Jump Financial opened 727 new positions and closed 516 in Q2 2025.
  • Jump Financial's portfolio value rose 25% quarter-over-quarter to $9.08B.

Based on Jump Financial's 13F filing for Q2 2025, filed 13 Aug 2025.